Business description: PCAS

PCAS specializes in developing, manufacturing, and marketing fine and specialty chemicals. Sales are distributed by family of products as follows:

- synthesized pharmaceutical products (63.5%);

- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).

At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.

France accounts for 76% of net sales.

Number of employees: 1,178

Sales by Activity: PCAS

Fiscal Period: December 2019 (EUR) 2020 (EUR) 2021 (EUR) 2022 (EUR)

Pharmaceutical Synthesis

13Cr 14Cr 12Cr 14Cr

Fine Speciality Chemicals

7.33Cr 5.89Cr 6.74Cr 8.27Cr

Geographical breakdown of sales: PCAS

Fiscal Period: December 2019 (EUR) 2020 (EUR) 2021 (EUR) 2022 (EUR)

France

16Cr 16Cr 14Cr 17Cr

Other Areas

3.8Cr 3.89Cr 4.44Cr 5.43Cr

Executive Committee: PCAS

Manager TitleAgeSince
Chief Executive Officer 43 03/05/2025
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 01/03/1999

Composition of the Board of Directors: PCAS

Director TitleAgeSince
Director/Board Member 74 01/03/2014
Director/Board Member - -

Company details: PCAS

PCAS SA

21, Chemin de la Sauvegarde

69134, Écully

+33 1 69 09 77 85

http://www.pcas.com/
address PCAS(PCA)

Other Pharmaceuticals

Change 5-day change 1-year change 3-year change Capi.($)
+0.11%+2.76%+63.52%+115.51% 1,05500Cr
+0.27%+0.73%+51.33%+73.10% 65TCr
+0.73%+0.88%+20.70%+73.89% 47TCr
-1.36%-0.39%+40.20%+41.03% 35TCr
+1.34%+5.47%+23.37%+31.30% 27TCr
-0.48%-0.06%+13.56%+12.36% 26TCr
+0.85%+8.42%+53.17%+55.45% 22TCr
+0.85%+1.40%+35.78%+101.47% 19TCr
-0.30%-10.41%-27.62%-61.04% 17TCr
Average +0.13%+0.74%+30.45%+49.23% 40.43TCr
Weighted average by Cap. -0.05%+1.32%+40.69%+69.05%